Monday, November 9, 2026

USD/EUR Bearish Momentum: 0.99% Down In The Last 10 Sessions

USD/EUR Bearish Momentum: 0.99% Down In The Last 10 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 0.99% for the last 10 sessions. At 09:07 EST on Thursday, 15 June, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 2.03% up from its 52-week low and 12.259% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.25%, a negative 0.01%, and a positive 0.38%, respectively.

USD/EUR's highest amplitude of average volatility was 0.36% (last week), 0.28% (last month), and 0.38% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • Eur/usd can consolidate above 1.08 and start rising towards 1.10 on doubts that fed will hike in July – socgen. According to FXStreet on Tuesday, 13 June, "If we start to doubt the Fed will hike in July, EUR/USD can consolidate above 1.08 and start heading back towards 1.10, while the Dollar drifts lower across the board. ", "From here, getting EUR/USD back to 1.15 in H2 probably requires the ECB to deliver at least 50 bps more hikes than the Fed, as per our economists' forecasts."
  • Eur/usd climbs past 1.0800 in the wake of US CPI. According to FXStreet on Tuesday, 13 June, "The upside momentum in EUR/USD gathers extra impulse and appears to surpass the 1.0800 hurdle in a more convincing fashion following the release of US inflation figures measured by the CPI."
  • According to FXStreet on Tuesday, 13 June, "The EUR/USD pair has attracted investors' attention amid a firmer risk-appetite theme and hopes of a decline in the Federal Reserve (Fed)-European Central Bank (ECB) policy divergence.", "Buyers could show more interest if the EUR/USD manages to sustain comfortably above 1.0800. "
  • Eur/usd forex signal: rising to test resistance in $1.08 area - 13 June 2023. According to DailyForex on Tuesday, 13 June, "My previous EUR/USD signal on 6th June was not triggered, as there was no bullish price action when the price first reached the area of identified support at $1.0704.", "In my previous analysis of the EUR/USD currency pair, I said that the technical picture looked choppy between $1.0625 and $1.0800. "
  • Eur/usd: wait for the FOMC meeting regardless of how the US CPI data turns out – commerzbank. According to FXStreet on Tuesday, 13 June, "Ahead of the Fed meeting tomorrow and the ECB meeting on Thursday the FX trade in EUR/USD has become a bit sluggish. ", "And even then, the last word has not yet been spoken in EUR/USD as what will matter on Thursday is how hawkish the ECB will sound and whether it might provide an indication as to where it expects its terminal rate to be."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cycle: Data Readouts, FDA Decisions and Capital-Allocation Shifts
From late October to January, mid-cap biotechs move through a dense run of events: ESMO and AHA/AASLD data presentations, Q3 earnings, and FDA PDUFA dates for ivonescimab (Nov 14) and lorundrostat (Dec 22). Alongside the regulatory news, companies are changing how they allocate capital: one lowered FY2026 R&D and SG&A guidance and pushed milestones into 2027, one authorized a $400M buyback, and one scheduled a delisting vote (EGM Nov 19, application Jan 25). Value is concentrating in a few binary regulatory and Phase 3 outcomes (Maritime-1 and ECLIPSE 2/3 readouts around Q1 2027), so sentiment is mixed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,558 source documents archived
Query this data → isubstrate.com